Clinical Application of Remifentanil Combined with Sevoflurane in Manual Reduction of Humeral Supracondylar Fracture in Children

OBJECTIVE: To explore the effect of the combination of remifentanil and sevoflurane on children with humeral supracondylar fractures undergoing manual reduction. METHODS: A total of 60 children undergoing manual reduction external fixation due to humeral supracondylar fractures were enrolled between September 2020 and September 2021. According to the random number table method, they were divided into the control group (inhalation of 7% sevoflurane) and the observation group (inhalation of 7% sevoflurane and intravenous infusion of remifentanil). The heart rate (HR), mean arterial pressure (MAP), and blood oxygen saturation (SpO(2)) in both groups were investigated. The sedation and analgesic effects, fracture reduction, and complications were compared between the two groups. RESULTS: There was no significant difference found in HR, MAP, or SpO(2) between the two groups at 3 minutes prior to anesthesia, 2 minutes post anesthesia, and post manual reduction (P > 0.05). The difference in HR, MAP, and SpO(2) between the two groups was not statistically significant at any time point (P > 0.05). The good rate of sedation and analgesia in the observation group was 93.33%, which is significantly higher than that in the control group (P < 0.05). The reduction time and success rate of one-time manual reduction in the observation group were higher than those in the control group (P < 0.05). There was no significant difference in fracture healing time between the two groups (P > 0.05). Both groups had airway complications (nausea and vomiting, neurovascular damage and asphyxia, and laryngospasm). CONCLUSION: The combination of remifentanil and sevoflurane showed good sedative and analgesic effects on children with humeral supracondylar fractures undergoing manual reduction with relatively higher safety.